Nutritional Assessment in Non-tuberculous Mycobacteria Pulmonary Disease
nutriNTM
nutriNTM
Sponsor study identifier
observational
120
1 country
1
Study Start
April 20, 2022
Actual (reported)Primary Completion
April 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Non-tuberculous mycobacterial (NTM) pulmonary disease (PD) is an emerging condition with heterogeneous manifestations from both the microbiological and the clinical point of view. Diagnostic and therapeutic guidelines are available but there are still unmet patients' and physicians' needs, including the exams to perform in the nutritional evaluation and intervention to improve health-related QoL and to control gastrointestinal side-effects during antimicrobial therapy, particularly in those with low body mass index and history of weight loss.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 20, 2022
Actual (reported)May 11, 2022
Actual (reported)May 17, 2022
Actual (reported)April 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
BMI (body mass index)
kg/m2
baseline (NTM-PD diagnosis)
FFMI (fat free mass index)
baseline (NTM-PD diagnosis), 6-month follow-up, 12-month follow-up
SMI (skeletal muscle mass index)
baseline (NTM-PD diagnosis), 6-month follow-up, 12-month follow-up
BFMI (body fat mass index)
baseline (NTM-PD diagnosis), 6-month follow-up, 12-month follow-up
Hand grip
baseline (NTM-PD diagnosis), 6-month follow-up, 12-month follow-up
Abdominal circumference
baseline (NTM-PD diagnosis), 6-month follow-up, 12-month follow-up
Adults with a recent diagnosis of NTM-PD
IRCCS San Gerardo dei Tintori
Monza, MB, 20900, Italy
First Submitted
May 11, 2022
First Posted
May 17, 2022
Study Start
April 20, 2022
Actual (reported)Primary Completion
April 30, 2024
Estimated (date passed)Mycobacteria Registry Study: Prospective Observational Study in Austria
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 11, 2024
Record last verified: 2024-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: